Barclays
BNTX icon

Barclays’s BioNTech BNTX Stock Holding History

Barclays’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-30,000
Closed -$3.19M – 5494
2025
Q2 		$3.19M Buy
30,000
+7,500
+33% +$758K ﹤0.01% 2496
2025
Q1 		$2.05M Hold
22,500
– – ﹤0.01% 2609
2024
Q4 		$2.56M Buy
+22,500
New +$2.57M ﹤0.01% 2702
2023
Q1 		– Sell
-36,900
Closed -$5.54M – 5104
2022
Q4 		$5.54M Buy
+36,900
New +$5.68M ﹤0.01% 1549

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Barclays's BNTX Position: Q2 2026 in Review

Barclays increased its BioNTech (BNTX) stake by 21% in Q2 2026, buying an estimated $3.03M and bringing the position to 184,663 shares worth $17.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1213.

Barclays first reported a position in BNTX in Q1 2022 and has held it in 18 quarters since. The position peaked at $26.1M in Q1 2022. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Barclays held 184,663 shares of BioNTech worth $17.2M as of Q2 2026.
  • Barclays bought 32,190 BioNTech shares in Q2 2026, an estimated $3.03M.
  • BioNTech made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #1213 holding.
  • Barclays first reported a position in BioNTech in Q1 2022 and has held it in 18 quarters since.
  • Barclays's BioNTech position peaked at $26.1M in Q1 2022.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.